Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K090631
    Date Cleared
    2009-04-16

    (38 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K935426, K973046, K042412

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The PAJUNK Balloon systems are indicated for patients undergoing laparoscopic surgical procedures requiring a sealed port of access and / or tissue retraction. This is also indicated in patients undergoing laparoscopic surgery requiring a sealed port of access and / or tissue separation in extraperitoneal procedures, such as in hernia repair.

    The PAJUNK Obturator is intended for use in establishing a port of access for insertion of endoscopic instruments into the abdominal cavity or extraperitoneal space in abdominal and extraperitoneal surgery.

    Device Description

    The PAJUNK® Balloon Systems for dilation facilitate safe and effective dissection of the preperitoneal space under direct view. Orientation during minimal invasive procedures is made easier. Three different shaped balloons are available for either unilateral purposes.

    The structural balloon is particularly suitable for preperitoneal access. The design of the balloon simplifies the separation of the peritoneum from the abdominal wall. Additionally it prevents the peritoneal space from collapsing in the case of a loss of gas.

    The ring-anchor balloon is also suitable for gastight accessing of the preperitoneal space. The seal is made by inflating the ring-anchor balloon and then advancing and securing the fastening device. Insufflation is performed via the built-in stop cock.

    AI/ML Overview

    The provided document is a 510(k) Premarket Notification Submission for PAJUNK®'s Balloons and Balloon Systems. This type of submission is for medical devices that are substantially equivalent to a predicate device already on the market, and therefore, it does not typically involve the rigorous performance studies with acceptance criteria, human readers, and ground truth establishment that are common for novel or high-risk devices, especially AI/ML-driven ones.

    Instead, the submission focuses on demonstrating substantial equivalence through comparisons to existing predicate devices, bench testing, and validated sterilization processes. Therefore, the specific information requested in the prompt regarding acceptance criteria, study details, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, and ground truth establishment for a test set and training set is not present in this document.

    The document states: "The comparison of the predicate devices and the subject device in section 12 of this submission as well as the validated sterilization process and the results of the bench testing and bench marking demonstrates that the proposed devices are substantially equivalent to the predicate devices and identical in technical description to devices already cleared for market and therefore demonstrated to be safe and effective. Based on the clinical evaluation, the biocompatibility testing and the bench testing conducted, safety and effectiveness as well as efficacy of PAJUNK® s balloons and balloon systema for dilation and fixation is proven."

    This indicates that the "study" demonstrating the device meets "acceptance criteria" (in this context, substantial equivalence to predicate devices and demonstrating safety and effectiveness) relies on:

    • Comparison to predicate devices: Establishing that the new device has similar technological characteristics and performs similarly to devices already cleared by the FDA.
    • Validated sterilization process: Demonstrating that the sterilization method is effective.
    • Bench testing: In-vitro mechanical or functional tests to ensure the device performs as intended (e.g., balloon integrity, inflation/deflation, sealing).
    • Biocompatibility testing: To ensure the materials used are safe for contact with the body.
    • Clinical evaluation: While not explicitly detailed as a new clinical trial, this likely refers to a review of existing clinical data or literature supporting the function of similar devices.

    Without further sections of the submission (e.g., "Section 12"), the specific details of these comparisons and tests, including any numerical acceptance criteria or detailed results, are not available in the provided text.

    In summary, the requested information is not applicable to this 510(k) submission document, as it is not a study of an AI/ML device with performance metrics based on data and ground truth as implied by the questions.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1